What are the best practices for ordering labs in a psychiatry setting?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Best Practices for Laboratory Testing in Psychiatric Settings

Routine laboratory testing of all psychiatric patients is of very low yield and should be directed by the history and physical examination rather than performed as standard practice. 1

Evidence-Based Approach to Laboratory Testing

Initial Assessment

Laboratory testing in psychiatric settings should follow a targeted approach based on:

  • Patient's clinical presentation
  • Medical history
  • Medication regimen
  • Physical examination findings

Recommended Laboratory Testing Framework

For All New Psychiatric Patients:

  • Directed testing only - Laboratory evaluation should be guided by clinical findings rather than routine panels 1
  • Avoid extensive routine testing - False positive results are 8 times more common than true positives in psychiatric patients 2

For Specific Patient Populations:

Higher-risk groups that warrant more comprehensive laboratory evaluation include:

  • Patients >65 years of age
  • First-episode psychosis
  • History of substance use disorders
  • Disoriented patients
  • Patients with abnormal vital signs
  • Patients with medical comorbidities
  • Patients on psychotropic medications requiring monitoring

Laboratory Tests by Clinical Scenario

1. Initial Psychiatric Evaluation

For alert, cooperative patients with normal vital signs and noncontributory history/physical examination:

  • No routine laboratory testing needed 1
  • Consider targeted testing based on specific symptoms or risk factors

For patients with first-episode psychiatric symptoms:

  • Basic metabolic panel
  • Complete blood count
  • Thyroid function tests
  • Urinalysis
  • Consider toxicology screen if substance use suspected

2. Medication Monitoring

For patients on psychotropic medications:

  • Therapeutic drug monitoring (TDM) for medications with established therapeutic windows 3
  • Medication-specific monitoring:
    • Lithium: Serum levels, renal and thyroid function
    • Valproate: Serum levels, liver function, CBC
    • Clozapine: CBC with differential (due to risk of severe neutropenia) 4
    • Antipsychotics: Metabolic panel, lipid profile, glucose

3. Medical Clearance in Emergency Settings

For psychiatric patients in emergency departments:

  • Laboratory testing should be directed by history and physical examination 1
  • Urine drug screens have limited utility in altering immediate management 1
  • Consider basic metabolic panel, glucose, and targeted testing based on clinical presentation

Common Pitfalls to Avoid

  1. Overreliance on laboratory testing - Most abnormal results can be predicted by history and physical examination 5

  2. Attributing behavioral changes to psychiatric causes without adequate medical workup - Always consider medical causes of psychiatric symptoms 6

  3. Routine ordering of extensive test panels - This leads to many clinically insignificant findings that don't affect patient management 5

  4. Failure to recognize medication side effects or interactions - Consider medication effects when interpreting laboratory results 6

Efficient Testing Strategy

A more efficient testing approach would include:

  • For women: 9 targeted tests based on clinical presentation 2
  • For men: 13 targeted tests based on clinical presentation 2
  • For all patients: Consider serum glucose, BUN, creatinine, and urinalysis as the few tests with merit as broader screening tests in asymptomatic patients 5

Special Considerations

  • Therapeutic Drug Monitoring (TDM) is valuable for dose optimization, especially with uncertain drug adherence, suboptimal tolerability, non-response at therapeutic doses, or pharmacokinetic drug-drug interactions 3

  • Patient populations that benefit most from TDM include children, pregnant women, elderly patients, individuals with intellectual disabilities, forensic patients, and those with known or suspected pharmacokinetic abnormalities 3

  • Laboratory alert levels should be established for medications, requiring immediate notification of the treating physician when exceeded 3

By following these evidence-based guidelines for laboratory testing in psychiatric settings, clinicians can provide more efficient and cost-effective care while still ensuring appropriate medical evaluation of psychiatric patients.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Altered Mental Status Evaluation and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.